| Document Date: 2015-01-29 05:26:00
Open Document File Size: 190,80 KBShare Result on Facebook
City London / / Company AEs / / Country United Kingdom / / / Event Product Recall / Product Issues / / Facility Canary Wharf / / IndustryTerm paediatric products / atypical and conventional antipsychotic medicinal products / Eligible products / Treatment of adults with previously treated anaplastic lymphoma / treatment of moderate to severe irritable bowel syndrome / Treatment of diabetes / medicinal products / / MedicalCondition ataxia / overactive bladder / partial-onset seizures / hypertension / schizophrenia / CV diseases / As dizziness / diabetes / balance disorder / orthostatic hypotension / fatigue / diabetes mellitus / severe irritable bowel syndrome / positive advanced non-small cell lung cancer / balance disorders / epilepsy / anaplastic lymphoma kinase / dizziness / constipation / secondarily generalised seizures / syndrome / bipolar disorder / dehydration / / Organization European Medicines Agency / European Union / E-mail info@ema.europa.eu Website www.ema.europa.eu An / / / Position physician / / Product Withdrawn 3 / / PublishedMedium the Peer review / / Technology pharmacokinetics / / URL www.ema.europa.eu / /
SocialTag |
Product Information Report Analysis 2013